Quality-of-life outcomes in long-term survivors of advanced prostate cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 4, 1998, Pages 327-332

  Litwin, Mark S ^a,b   Shpall, Andrew I ^a   Dorey, Frederick ^a   Nguyen, Thanh Hai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hormone therapy; Metastatic disease; Orchiectomy; Outcomes assessment; Prostatic neoplasms; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CASTRATION; CONTROLLED STUDY; EMOTIONAL STABILITY; FATIGUE; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; ORCHIECTOMY; OUTCOMES RESEARCH; PHYSICAL CAPACITY; PROSTATE CANCER; QUALITY OF LIFE; SEXUAL FUNCTION; SOCIAL ADAPTATION;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; DECISION MAKING; HUMANS; LONGITUDINAL STUDIES; MALE; NEOPLASM METASTASIS; ORCHIECTOMY; PATIENT PARTICIPATION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; SURVIVORS;

EID: 0031817247     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199808000-00002     Document Type: Article

References (20)

1. Singer PA, Tasch ES, Stocking C, et al. Sex or survival: tradeoffs between quality and quantity of life. J Clin Oncol 1991;9:328-34.
2. Mazur DJ, Merz JF. How older patients' treatment preference are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer. J Amer Geriatr Soc 1996;44:934-7.
3. Krongrad A, Lai H, Burke MA, et al. Marriage and mortality in prostate cancer. J Urol 1996;156:1696-700.
4. Hays RD, Sherbourne CD. The RAND 36-item health survey 1.0. Med Care 1993;2:217-27.
5. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
6. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care 1992;30:473-83.
7. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-35.
8. Ware JE, Kosinski M, Keller SK. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute, New England Medical Center, 1994.
9. Jaeschke R, Singer J, Guyatt GH, et al. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
10. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81-7.
11. Macfarlane GJ, Botto H, Sagnier PP, et al. The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol 1996;49:1171-6.
12. Cassileth BR, Soloway MS, Vogelzang NJ, et al. Patients' choice of treatment in stage D prostate cancer. Urology 1989;33(suppl):57-62.
13. Cassileth BR, Soloway MS, Vogelzang NJ, et al. Quality of life and psychosocial status in stage D prostate cancer. Qual Life Res 1992;1:323-9.
14. Herr HW, Kornblith AB, Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 1993;71(suppl):1143-50.
15. Tannock IF, Gospodarowicz M, Panzarella T, et al. Treatment of metastatic prostate cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 1989;7:1-7.
16. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1975;1:277-99.
17. Cleary PD, Morrissey G, Oster G. Health-related quality of life in patients with advanced prostate cancer: a multinational perspective. Qual Life Res 1995;4:207-20.
18. Ganz PA, Schag CAC, Lee JJ, et al. The CARES: a generic measure of health related quality of life for patients with cancer. Qual Life Res 1992;1:19-29.
19. Kornblith AB, Herr HW, Ofman US. Quality of life of patients with prostate cancer and their spouses. Cancer 1994;73:2791-802.
20. Fossa SD, Aaronson NK, Newling D, et al. Quality of life and treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer 1990;11:1133-6.